Delivery Order SPE2DB22D1017-SPE2DB25FG8NE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,747.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed-price delivery order issued under a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical supply needs, particularly supporting...
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,056.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 21, 2025, with completion targeted for July 22, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is being performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $12,775.35 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on August 5, 2025, with completion expected by August 6, 2025. The contract utilizes a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $45,611.82 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside provisions and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a standard pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,942.16 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- The Defense Logistics Agency awarded a delivery order valued at $1,470.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 7, 2025, with completion scheduled for August 8, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award conditions. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,087.41 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pediatric pharmaceutical supply requirement for federal military and healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8NEDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $4,232.05 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with a completion date of July 31, 2025. This contract employs a firm fixed-price arrangement with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order aligns with DLA's broader pharmaceutical procurement strategy to ensure consistent availability of critical medications for military medical facilities and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 7/30/25 |